Top Markets
Coin of the day
Invivyd, Inc. Invivyd, Inc.

Invivyd, Inc.

IVVD
Hisse Senetlerindeki Sıralama #17262
Adagio Therapeutics, Inc., a biopharmaceutical firm in its clinical development... Adagio Therapeutics, Inc., a biopharmaceutical firm in its clinical development phase, operates within the United States, specializing in the discovery, progression, and marketing of antibody-derived solutions for infectious diseases. The company's leading drug candidate, ADG20 (adintrevimab), is a neutralizing antibody currently undergoing Phase 3 clinical investigation for both the management and prevention of coronavirus disease. Adagio Therapeutics maintains collaborative agreements with Adimab, LLC to facilitate the identification and enhancement of its exclusive antibodies. Furthermore, it partners with the Scripps Research Institute to conduct studies aimed at uncovering potential vaccine solutions for the prophylaxis, detection, or therapy of influenza or beta coronaviruses. Incorporated in 2020, the company's base of operations is in Waltham, Massachusetts.
Hisse Fiyatı
$0.8799
Son senkronizasyon: 2026-09-01
Piyasa Değeri
$259.22M
Değişim (1 gün)
-7.85%
Değişim (1 yıl)
-14.57%
Ülke
US
Ticaret Invivyd, Inc. (IVVD)

Kategori

Invivyd, Inc. (IVVD) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $0.85 - 2026-09-01

Gün sonu en düşük fiyat: $27.68 - 2021-08-01
Invivyd, Inc. için hisse fiyatı geçmişi: 2021 - 2026
Yıllık Hisse Fiyatı Performansı
Yıl Performans
2026 (TTM) -37.40%
2025 355.72%
2024 -79.42%
2023 46.08%
2022 -91.63%
2021 0.00%
Benzer şirketler veya rakiplerin hisse fiyatı
Şirket Hisse fiyatı Değişim 1yıl% Ülke
$550.65 37.32%
US
$1.05K 48.27%
NL
$148.50 513.89%
US
$122.21 -10.03%
AU
$763.69 9.05%
CH